XTL Biopharmaceutica (Israel) Probability of Future Stock Price Finishing Over 12.08

XTL Biopharmaceutica's future price is the expected price of XTL Biopharmaceutica instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of XTL Biopharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
Please specify XTL Biopharmaceutica's target price for which you would like XTL Biopharmaceutica odds to be computed.

XTL Biopharmaceutica Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XTL Biopharmaceutica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XTL Biopharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
XTL Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years
XTL Biopharmaceuticals has accumulated about 5.06 M in cash with (1.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 16.0% of the company outstanding shares are owned by insiders

XTL Biopharmaceutica Technical Analysis

XTL Biopharmaceutica's future price can be derived by breaking down and analyzing its technical indicators over time. XTL Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XTL Biopharmaceuticals. In general, you should focus on analyzing XTL Stock price patterns and their correlations with different microeconomic environments and drivers.

XTL Biopharmaceutica Predictive Forecast Models

XTL Biopharmaceutica's time-series forecasting models is one of many XTL Biopharmaceutica's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary XTL Biopharmaceutica's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about XTL Biopharmaceuticals

Checking the ongoing alerts about XTL Biopharmaceutica for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for XTL Biopharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
XTL Biopharmaceutica generated a negative expected return over the last 90 days
XTL Biopharmaceutica has high historical volatility and very poor performance
XTL Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years
XTL Biopharmaceuticals has accumulated about 5.06 M in cash with (1.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 16.0% of the company outstanding shares are owned by insiders

Other Information on Investing in XTL Stock

XTL Biopharmaceutica financial ratios help investors to determine whether XTL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTL with respect to the benefits of owning XTL Biopharmaceutica security.